Denali Therapeutics and Biogen Announce Initiation of Phase 2b Study of LRRK2 Inhibitor in Parkinson’s Disease May 31, 2022
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment May 24, 2022
AppliedVR Partners with Kernel to Measure Brain Activity Changes Before, During, and After Virtual Reality (VR) Treatment of Chronic Pain May 17, 2022